Tempus AI, Inc. logo
Tempus AI, Inc. (TEM)
Compare

Tempus AI, Inc. (TEM) EV/Sales Ratio: 6.72x

popular:market cap|pe ratio|revenue|price history|total return

Is Tempus AI, Inc.’s EV/Sales ratio high or low?

Tempus AI, Inc.'s EV/Sales ratio of 6.72x is 45% below its 2-year average of 12.18x, near the low end of its 2-year range (5.94x–23.26x).

As of Friday, June 12, 2026. 41.39% below its 12-month average of 11.47x.

EV/EBITDA|P/S Ratio|Revenue|All Metrics

TEM EV/Sales Ratio Chart

TEM EV/Sales Ratio
6.72x-57.74% 1Y
Zoom

TEM Average EV/Sales Ratio Chart

TEM Current vs Average EV/Sales Ratio Chart

TEM EV/Sales Ratio Metrics

EV/SALES RATIO

6.72x

EV/SALES RATIO AVG TTM

11.47x

EV/SALES RATIO AVG 3Y

12.18x

EV/SALES RATIO AVG 5Y

12.18x

EV/SALES RATIO AVG 10Y

12.18x

EV/SALES RATIO AVG 15Y

12.18x

EV/SALES RATIO AVG 20Y

12.18x

CURRENT VS TTM AVG

-41.39%

CURRENT VS 3Y AVG

-44.82%

CURRENT VS 5Y AVG

-44.82%

CURRENT VS 10Y AVG

-44.82%

CURRENT VS 15Y AVG

-44.82%

CURRENT VS 20Y AVG

-44.82%

TEM Competitors' EV/Sales Ratio

NAMEMARKET CAPEV/SALES RATIOTTM3Y5Y
Tempus AI, Inc. (TEM)$8.65B6.72x11.47x12.18x12.18x
Charles River Laboratories International, Inc. (CRL)$9.06B3.00x2.79x3.02x3.79x
Bio-Rad Laboratories, Inc. (BIO)$7.91B3.38x3.41x3.67x4.57x
Baxter International Inc. (BAX)$10.58B1.61x1.72x2.17x2.64x
Hims & Hers Health, Inc. (HIMS)$6.19B3.06x4.73x4.20x4.27x
Align Technology, Inc. (ALGN)$12.64B2.85x2.73x4.07x5.91x
Solventum Corporation (SOLV)$13.72B2.23x2.19x2.26x2.26x
Hologic, Inc. (HOLX)$16.97B4.25x4.02x4.39x4.15x
23andMe Holding Co. (ME)$15.31M0.02x0.35x0.71x3.53x
Moderna, Inc. (MRNA)$19.70B8.54x5.96x5.02x6.82x

Understanding EV/Sales

Enterprise Value (EV) = Market Cap + Total Debt - Cash

Sales = Total Revenue (TTM)

EV/Sales is commonly used because:

  • It works for unprofitable companies where P/E doesn't apply
  • Revenue is harder to manipulate than earnings
  • It supports comparisons across companies at different profitability stages
  • It is frequently used for software and other revenue-growth-focused companies

Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.

Tempus AI, Inc. EV/Sales Ratio Formula & Definition

EV/Sales = Enterprise Value / Revenue (TTM)

Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Tempus AI, Inc. EV/Sales Ratio FAQ

What is the EV/Sales ratio for Tempus AI, Inc. (TEM)?
The EV/Sales ratio for TEM stock is 6.72x.
Is Tempus AI, Inc.'s EV/Sales ratio high or low?
Tempus AI, Inc.'s EV/Sales ratio of 6.72x is 45% below its 2-year average of 12.18x, near the low end of its 2-year range (5.94x–23.26x).
What is the TTM average EV/Sales ratio for Tempus AI, Inc. (TEM)?
The TTM average EV/Sales ratio for TEM stock is 11.47x.
What is the 3Y average EV/Sales ratio for Tempus AI, Inc. (TEM)?
The 3Y average EV/Sales ratio for TEM stock is 12.18x.
What is the 5Y average EV/Sales ratio for Tempus AI, Inc. (TEM)?
The 5Y average EV/Sales ratio for TEM stock is 12.18x.
What is the 10Y average EV/Sales ratio for Tempus AI, Inc. (TEM)?
The 10Y average EV/Sales ratio for TEM stock is 12.18x.
What is the 15Y average EV/Sales ratio for Tempus AI, Inc. (TEM)?
The 15Y average EV/Sales ratio for TEM stock is 12.18x.
What is the 20Y average EV/Sales ratio for Tempus AI, Inc. (TEM)?
The 20Y average EV/Sales ratio for TEM stock is 12.18x.

Tempus AI, Inc. EV/Sales Ratio History

DATEEV/SALES RATIO
2026-06-116.72x
2026-06-106.71x
2026-06-096.62x
2026-06-086.59x
2026-06-056.31x
2026-06-047.07x
2026-06-036.45x
2026-06-026.72x
2026-06-017.14x
2026-05-296.84x
2026-05-286.94x
2026-05-276.40x
2026-05-266.34x
2026-05-226.27x
2026-05-216.31x
2026-05-206.23x
2026-05-196.19x
2026-05-185.94x
2026-05-155.98x
2026-05-146.18x
2026-05-136.24x
2026-05-126.37x
2026-05-116.57x
2026-05-086.76x
2026-05-076.71x
2026-05-067.23x
2026-05-057.31x
2026-05-047.81x
2026-05-017.70x
2026-04-307.77x
2026-04-297.02x
2026-04-287.17x
2026-04-277.38x
2026-04-247.31x
2026-04-237.21x
2026-04-227.77x
2026-04-217.72x
2026-04-207.95x
2026-04-177.82x
2026-04-167.62x
2026-04-157.90x
2026-04-146.95x
2026-04-136.47x
2026-04-106.05x
2026-04-096.22x
2026-04-086.67x
2026-04-076.58x
2026-04-066.65x
2026-04-026.66x
2026-04-016.61x
2026-03-316.36x
2026-03-305.97x
2026-03-276.01x
2026-03-266.40x
2026-03-256.57x
2026-03-246.86x
2026-03-236.90x
2026-03-206.60x
2026-03-196.84x
2026-03-186.84x
2026-03-177.13x
2026-03-167.14x
2026-03-137.01x
2026-03-126.95x
2026-03-117.38x
2026-03-107.14x
2026-03-097.33x
2026-03-067.33x
2026-03-057.43x
2026-03-047.19x
2026-03-037.21x
2026-03-027.47x
2026-02-277.46x
2026-02-267.76x
2026-02-257.53x
2026-02-248.11x
2026-02-239.68x
2026-02-209.85x
2026-02-1910.11x
2026-02-189.50x
2026-02-178.93x
2026-02-138.84x
2026-02-128.65x
2026-02-119.10x
2026-02-109.46x
2026-02-099.66x
2026-02-069.31x
2026-02-058.92x
2026-02-049.09x
2026-02-039.47x
2026-02-029.88x
2026-01-3010.08x
2026-01-2910.67x
2026-01-2810.84x
2026-01-2711.19x
2026-01-2611.32x
2026-01-2310.95x
2026-01-2211.44x
2026-01-2110.95x
2026-01-2011.19x
2026-01-1611.75x
2026-01-1511.52x
2026-01-1411.58x
2026-01-1311.24x
2026-01-1211.58x
2026-01-0911.10x
2026-01-0811.44x
2026-01-0711.66x
2026-01-0611.62x
2026-01-0510.86x
2026-01-0210.49x
2025-12-319.96x
2025-12-3010.17x
2025-12-2910.34x
2025-12-2610.54x
2025-12-2410.79x
2025-12-2310.86x
2025-12-2211.05x
2025-12-1910.82x
2025-12-1810.46x
2025-12-1710.84x
2025-12-1611.40x
2025-12-1511.48x
2025-12-1211.79x
2025-12-1112.31x
2025-12-1012.50x
2025-12-0912.63x
2025-12-0812.81x
2025-12-0512.75x
2025-12-0412.70x
2025-12-0312.47x
2025-12-0212.32x
2025-12-0112.34x
2025-11-2812.95x
2025-11-2612.84x
2025-11-2512.78x
2025-11-2412.65x
2025-11-2111.74x
2025-11-2011.01x
2025-11-1911.55x
2025-11-1811.18x
2025-11-1711.12x
2025-11-1411.45x
2025-11-1311.37x
2025-11-1211.87x
2025-11-1111.94x
2025-11-1011.98x
2025-11-0711.94x
2025-11-0612.03x
2025-11-0513.64x
2025-11-0413.99x
2025-11-0316.86x
2025-10-3117.06x
2025-10-3016.41x
2025-10-2916.88x
2025-10-2816.47x
2025-10-2717.38x
2025-10-2416.95x
2025-10-2316.55x
2025-10-2216.23x
2025-10-2116.93x
2025-10-2017.54x
2025-10-1716.69x
2025-10-1617.28x
2025-10-1517.44x
2025-10-1417.07x
2025-10-1317.91x
2025-10-1018.26x
2025-10-0918.78x
2025-10-0819.51x
2025-10-0717.64x
2025-10-0617.65x
2025-10-0317.39x
2025-10-0216.96x
2025-10-0116.73x
2025-09-3015.40x
2025-09-2915.01x
2025-09-2614.99x
2025-09-2514.78x
2025-09-2415.13x
2025-09-2316.02x
2025-09-2216.34x
2025-09-1916.77x
2025-09-1816.56x
2025-09-1716.45x
2025-09-1616.55x
2025-09-1516.21x
2025-09-1216.43x
2025-09-1116.87x
2025-09-1014.94x
2025-09-0915.45x
2025-09-0815.31x
2025-09-0515.20x
2025-09-0414.93x
2025-09-0314.60x
2025-09-0214.97x
2025-08-2914.52x
2025-08-2814.12x
2025-08-2714.04x
2025-08-2614.60x
2025-08-2514.52x
2025-08-2215.37x
2025-08-2114.67x
2025-08-2014.05x
2025-08-1914.01x
2025-08-1814.99x
2025-08-1514.14x
2025-08-1413.74x
2025-08-1313.38x
2025-08-1212.78x
2025-08-1111.78x
2025-08-0811.79x
2025-08-0713.35x
2025-08-0612.67x
2025-08-0513.13x
2025-08-0413.09x
2025-08-0112.53x
2025-07-3112.89x
2025-07-3013.15x
2025-07-2913.25x
2025-07-2814.04x
2025-07-2514.57x
2025-07-2414.32x
2025-07-2314.65x
2025-07-2213.84x
2025-07-2113.19x
2025-07-1813.82x
2025-07-1713.75x
2025-07-1613.61x
2025-07-1512.74x
2025-07-1413.15x
2025-07-1112.95x
2025-07-1013.53x
2025-07-0913.28x
2025-07-0813.30x
2025-07-0713.19x
2025-07-0313.82x
2025-07-0213.44x
2025-07-0113.50x
2025-06-3014.37x
2025-06-2715.00x
2025-06-2615.38x
2025-06-2514.78x
2025-06-2415.37x
2025-06-2314.81x
2025-06-2015.38x
2025-06-1815.55x
2025-06-1715.76x
2025-06-1616.16x
2025-06-1316.01x
2025-06-1216.00x
2025-06-1115.90x
2025-06-1015.61x
2025-06-0915.09x
2025-06-0614.05x
2025-06-0513.33x
2025-06-0414.20x
2025-06-0314.03x
2025-06-0214.35x
2025-05-3012.59x

Showing the most recent 260 of 499 data points. The chart above shows the full history.

Related Metrics

EV/EBITDAP/S RatioRevenueAll Metrics

About Tempus AI, Inc.

Tempus AI, Inc. functions as a pioneering health technology enterprise. It specializes in delivering advanced diagnostic services, including cutting-edge genomic sequencing, PCR analysis, molecular genotyping, and various other anatomical and molecular pathology assessments. These vital services are provided to a diverse clientele, including medical practitioners, pharmaceutical companies, biotechnology innovators, scientific researchers, and other collaborating entities. The company offers "Insights," a licensed repository of de-identified clinical, molecular, and imaging data, complemented by a comprehensive suite of analytical and cloud-based computing services, primarily aimed at pharmaceutical and biotechnology firms. Additionally, its "Trials" program facilitates clinical trial matching services specifically for pharmaceutical companies. Tempus AI also manages several other platforms: "Next"; "Algos," a collection of algorithm-driven tests focused on oncology; "Hub," a versatile desktop and mobile application for ordering, managing, and receiving test results for patients; and "Lens," a dedicated portal enabling researchers and scientists to discover, access, and analyze the extensive Tempus dataset. Further demonstrating its commitment to innovation, Tempus AI has formed strategic alliances with AstraZeneca and Pathos AI, Inc. for the co-development of oncological therapeutic initiatives. Established in 2015, the company was initially known as Tempus Labs, Inc. before officially rebranding to Tempus AI, Inc. in January 2023. Its operations are based out of Chicago, Illinois.

Chicago, IL
2,400 employees
www.tempus.com
Healthcare / Medical - Healthcare Information Services
Sector
Healthcare
Industry
Medical - Healthcare Information Services
CEO
Eric Lefkofsky
View full financials